One study described that SIRT1 was significantly overexpressed in type I EC compared to normal endometrial tissue, and this overexpression correlates with improved progression-free survival, suggesting a potential tumor-suppressive role in this subtype [108]. This evidence concerns the gene SIRT1 and neoplasm.